{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:28:35Z","timestamp":1783481315847,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21OC0067235"],"award-info":[{"award-number":["NNF21OC0067235"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijid.2025.108032","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:20:46Z","timestamp":1756398046000},"page":"108032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Classic pathway persistent complement activation is associated with specific symptoms in individuals with post\u2013COVID-19 condition: A case-control study"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3772-9690","authenticated-orcid":false,"given":"C\u00e9sar","family":"Fern\u00e1ndez-de-las-Pe\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ruiz-Ruig\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Esparcia-Pinedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Colom-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cava-Valenciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Torres-Macho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Arrieta-Ortubay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00edriam","family":"Akasbi-Moltalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lumbreras-Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Arendt-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Franco-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108032_bib0001","unstructured":"World Health Organization. Coronavirus (COVID-19) Dashboard, https:\/\/covid19.who.int\/; n.d. [accessed 01 July 2025]."},{"key":"10.1016\/j.ijid.2025.108032_bib0002","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1007\/s10238-023-01204-z","article-title":"Vaccine effectiveness of COVID-19 and rebound in the real world","volume":"23","author":"Park","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ijid.2025.108032_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00430-021-00704-7","article-title":"An update: the emerging evidence of complement involvement in COVID19","volume":"210","author":"Li","year":"2021","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijid.2025.108032_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767981","article-title":"SARS-CoV-2 antibodies mediate complement and cellular driven inflammation","volume":"12","author":"Jarlhelt","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.108032_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696085","article-title":"Serum complement C3 and C4 and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression","volume":"12","author":"Zinellu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.108032_bib0006","doi-asserted-by":"crossref","first-page":"eabj1014","DOI":"10.1126\/sciimmunol.abj1014","article-title":"Complement control for COVID-19","volume":"6","author":"Bosmann","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2025.108032_bib0007","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108032_bib0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinf.2023.12.004","article-title":"Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: a systematic review and meta-analysis","volume":"88","author":"Fernandez-de-las-Pe\u00f1as","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.108032_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70429","article-title":"Long-term sequelae of COVID-19: A systematic review and meta-analysis of symptoms 3 years post-SARS-CoV-2 infection","volume":"97","author":"Rahmati","year":"2025","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2025.108032_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106235","article-title":"Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England","volume":"89","author":"Wang","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.108032_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2023.05.003","article-title":"Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: a systematic review and meta-analysis","volume":"134","author":"Kuodi","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108032_bib0012","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.3390\/microorganisms11122959","article-title":"COVID or post-COVID-19 condition: past, present and future research directions","volume":"11","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijid.2025.108032_bib0013","doi-asserted-by":"crossref","first-page":"eadg7942","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long COVID","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ijid.2025.108032_bib0014","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jiac.2023.10.016","article-title":"Relevance of complement immunity with brain fog in patients with long COVID","volume":"30","author":"Hagiya","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2025.108032_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.medj.2024.01.011","article-title":"Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID","volume":"5","author":"Baillie","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.ijid.2025.108032_bib0016","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108032_bib0017","series-title":"Hospital anxiety and depression scale \u2013 deutsche version (HADS-D)","author":"Herrmann-Lingen","year":"2011"},{"key":"10.1016\/j.ijid.2025.108032_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.ijid.2025.108032_bib0019","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.2196\/jmir.2818","article-title":"Telephone versus internet administration of self-report measures of social anxiety, depressive symptoms, and insomnia: psychometric evaluation of a method to reduce the impact of missing data","volume":"15","author":"Hedman","year":"2013","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.ijid.2025.108032_bib0020","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.3390\/ijerph19159273","article-title":"Psychometric properties of the hospital anxiety and depression scale (HADS) in previously hospitalized COVID-19 patients","volume":"19","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijid.2025.108032_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191811460","article-title":"Psychometric properties of the functional impairment checklist (FIC) as a disease-specific patient-reported outcome measure (PROM) in previously hospitalized COVID-19 survivors with long-COVID","volume":"19","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijid.2025.108032_bib0022","first-page":"S157","article-title":"Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sj\u00f6gren's syndrome adults from a defined population","volume":"36","author":"Akiyama","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ijid.2025.108032_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAT.0000000000000042","article-title":"Complement C3 and its polymorphism: biological and clinical consequences","volume":"46","author":"Delanghe","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.ijid.2025.108032_bib0024","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1515\/cclm-2021-0902","article-title":"Evaluation of reference intervals for classical and alternative pathway functional complement assays","volume":"60","author":"Capiau","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ijid.2025.108032_bib0025","doi-asserted-by":"crossref","first-page":"eadi0252","DOI":"10.1126\/scitranslmed.adi0252","article-title":"A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19","volume":"15","author":"Van Damme","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2025.108032_bib0026","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system Part II: Role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.108032_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1216457","article-title":"COVID, complement, and the brain","volume":"14","author":"Vlaicu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.108032_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100995","article-title":"Complement activation in COVID-19 and targeted therapeutic options: a scoping review","volume":"57","author":"Lim","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.ijid.2025.108032_bib0029","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.2147\/DMSO.S480457","article-title":"Type 2 diabetes mellitus aggravates complement dysregulation and affects cortisol response in patients with post-COVID-19","volume":"17","author":"Ji","year":"2024","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:28:38Z","timestamp":1772882918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225002541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"alternative-id":["S1201971225002541"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108032","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classic pathway persistent complement activation is associated with specific symptoms in individuals with post\u2013COVID-19 condition: A case-control study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108032"}}